DH
Dr Harry Dietz BOARD MEMBER
Insider track record Other Across 6 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Discover the complete record of transactions filed by Dr Harry Dietz. Insider active across 1 company, notably GSK plc. Cumulatively, 15 filings have been logged. Activity tracked since 20 June 2023. The latest transaction was disclosed on 9 April 2026 (Purchase). Regulator: RNS (LSE). The full history is free.
Declarations 15 total
● Independent Non-Executive Director · Executives · 9 Apr 2026 · GSK plc 30 shares @ £0.5893 0.0000% mcap 5.1% of flow US37733W2044⌘ RNS:ca89baf1-aabf-4020-b0fe-d5c65c1b3a57-14 Ideal exit: 4 Jan 2027 (T+270) ● Independent Non-Executive Director · Executives · 9 Jan 2026 · GSK plc 31 shares @ £0.5042 4.8% of flow US37733W2044⌘ RNS:07b8fade-09b6-4441-a582-c78ac4e1b6b3-38 Ideal exit: 6 Oct 2026 (T+270) ● Independent Non-Executive Director · Executives · 10 Oct 2025 · GSK plc 32 shares @ £0.4375 4.5% of flow US37733W2044⌘ RNS:5859068-29 Ideal exit: 7 Jul 2026 (T+270) ● Independent Non-Executive Director · Executives · 11 Jul 2025 · GSK plc 34 shares @ £0.3853 4.2% of flow US37733W2044⌘ RNS:5737340-36 Ideal exit: 7 Apr 2026 (T+270) ● Independent Non-Executive Director · Executives · 11 Apr 2025 · GSK plc 22 shares @ £0.3414 2.6% of flow US37733W2044⌘ RNS:5617047-4 Ideal exit: 6 Jan 2026 (T+270) ● Independent Non-Executive Director · Executives · 10 Jan 2025 · GSK plc 18 shares @ £0.3333 2.2% of flow US37733W2044⌘ RNS:5498728-20 Ideal exit: 7 Oct 2025 (T+270) ● Independent Non-Executive Director · Executives · 11 Oct 2024 · GSK plc 14 shares @ £0.3907 2.1% of flow US37733W2044⌘ RNS:5388451-4 Ideal exit: 8 Jul 2025 (T+270) ● Independent Non-Executive Director · Executives · 12 Jul 2024 · GSK plc 12 shares @ £0.3933 1.8% of flow US37733W2044⌘ RNS:5266837-14 Ideal exit: 8 Apr 2025 (T+270) ● Independent Non-Executive Director · Executives · 12 Apr 2024 · GSK plc 9 shares @ £0.41 1.4% of flow US37733W2044⌘ RNS:5143847-28 Ideal exit: 7 Jan 2025 (T+270) ● Independent Non-Executive Director · Executives · 12 Jan 2024 · GSK plc 6 shares @ £0.4017 0.9% of flow US37733W2044⌘ RNS:5034561-27 Ideal exit: 8 Oct 2024 (T+270) ● Independent Non-Executive Director · Executives · 20 Dec 2023 · GSK plc 227 shares @ £0.3662 32.9% of flow US37733W2044⌘ RNS:5012405-6 Ideal exit: 15 Sept 2024 (T+270) ● Independent Non-Executive Director · Executives · 13 Oct 2023 · GSK plc 4 shares @ £0.37 0.6% of flow US37733W2044⌘ RNS:4939502-6 Ideal exit: 9 Jul 2024 (T+270) ● Independent Non-Executive Director · Executives · 20 Sept 2023 · GSK plc 220 shares @ £0.3803 33.0% of flow US37733W2044⌘ RNS:4907954-5 Ideal exit: 16 Jun 2024 (T+270) ● Independent Non-Executive Director · Executives · 14 Jul 2023 · GSK plc 2 shares @ £0.35 0.8% of flow US37733W2044⌘ RNS:4837969-21 Ideal exit: 9 Apr 2024 (T+270) ● Independent Non-Executive Director · Executives · 20 Jun 2023 · GSK plc 240 shares @ £0.3474 99.2% of flow US37733W2044⌘ RNS:4813178-4 Ideal exit: 16 Mar 2024 (T+270) About Dr Harry Dietz Dr Harry Dietz is a declarant linked to GSK plc as an Independent Non-Executive Director. He has 15 filings in total, and, across the recent sample of 15 filings, the transactions are purchases for EUR 398, with no sales, between 2023-06-23 and 2026-04-16.